<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03123042</url>
  </required_header>
  <id_info>
    <org_study_id>1710162</org_study_id>
    <nct_id>NCT03123042</nct_id>
  </id_info>
  <brief_title>Feasibility Study of Sentinel Navigation Surgery After Non-curative Endoscopic Resection</brief_title>
  <acronym>SENORITA2</acronym>
  <official_title>Feasibility Study of Sentinel Navigation Surgery in Early Gastric Cancer Patients After Non-curative Endoscopic Resection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Cancer Center, Korea</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Center, Korea</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Purpose: To prove the feasibility of sentinel node navigation surgery (SNNS) in early gastric
      cancer patients with the risk of lymph node metastasis after endoscopic resection and
      preparation of multicenter phase 3 trial of stomach preserving surgery in these patients.

      Contents: The number of enrollment is 247 patients. The patients underwent endoscopic
      resection for early gastric cancer, and the tumor was defined to be out of indication for
      endoscopic resection pathologically. So, additional gastrectomy is recommended for them.

      The investigators will enroll patients who agree this study. After general anesthesia,
      Tc99m-Phytate with indocyanine green will be injected with endoscopy. Then sentinel basin
      will be detected using gamma probe and laparoscopic basin dissection will be done. Sentinel
      lymph node will be identify in back table dissection, and patients will undergo conventional
      gastrectomy. Detection rate and false negative rate will be evaluated by pathological review.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Sentinel basin dissection method

        1. endoscopic tracer injection after general anesthesia

        2. Tracer : Tc99m-phytate 3cc and indocyanine green 3cc mix --&gt; Injection of the probe
           (1cc/site, 4 sites) around endoscopic submucosal dissection ulcer scar

        3. Sentinel basin identification with laparoscopic probe

        4. Dissection of the sentinel basin

        5. Sentinel node dissection at back table

        6. Conventional laparoscopic gastrectomy
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">March 20, 2017</start_date>
  <completion_date type="Anticipated">December 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>detection rate (%)</measure>
    <time_frame>15 days after operation</time_frame>
    <description>number of patients whose sentinel nodes are detected / enrolled number of patients *100</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>False negative rate</measure>
    <time_frame>15 days after operation</time_frame>
    <description>number of patients without metastatic lymph node in sentinel basin / number of patients with metastatic lymph node *100</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">247</enrollment>
  <condition>Sentinel Lymph Node</condition>
  <condition>Early Gastric Cancer</condition>
  <arm_group>
    <arm_group_label>Sentinel basin dissection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention: Sentinel basin dissection</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Sentinel basin dissection</intervention_name>
    <description>Sentinel basin detection using endoscopic detector (Tc99m plus indocyanine green) injection and laparoscopic sentinel basin dissection. Then conventional gastrectomy</description>
    <arm_group_label>Sentinel basin dissection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  No limitation for age if the patient is available for gastrectomy

          -  Patient who underwent endoscopic submucosal dissection and the tumor was defined as
             out of indication.

        The expanded criteria for endoscopic resection are as follows

          -  criterion I: intramucosal tumor without ulcerative findings and of differentiated type
             with size &gt; 2 cm

          -  criterion II: intramucosal tumor with ulcerative findings and of differentiated type
             with size ≤ 3 cm

          -  criterion III: intramucosal tumor without ulcerative findings and of undifferentiated
             type with size &lt; 2 cm

          -  criterion IV, submucosal invasion &lt; 500 mm and of differentiated type with size ≤ 3
             cm)

          -  Eastern Cooperative Oncology Group (ECOG) performance scale 0 or 1

        Exclusion Criteria:

          -  Inoperative due to severe cardiovascular or pulmonary disease

          -  Pregnant

          -  Patients who had previous gastric surgery

          -  Patients who had previous upper abdomen surgery except cholecystectomy, or radiation
             therapy on upper abdomen, or hypersensitivity to any medicine
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bang Wool Eom, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Cancer Center, Korea</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bang Wool Eom, MD, PhD</last_name>
    <phone>82-31-920-1689</phone>
    <email>kneeling79@ncc.re.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Keun Won Ryu, MD.PhD</last_name>
    <phone>82-31-920-1628</phone>
    <email>docryu@ncc.re.kr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Bang Wool Eom</name>
      <address>
        <city>Goyang</city>
        <state>Gyeonggi-do</state>
        <zip>10408</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Bang Wool Eom, MD,PhD</last_name>
      <phone>82-31-920-1689</phone>
      <email>kneeling79@ncc.re.kr</email>
    </contact>
    <contact_backup>
      <last_name>Keun Won Ryu, MD,PhD</last_name>
      <phone>8-31-920-1628</phone>
      <email>docryu@ncc.re.kr</email>
    </contact_backup>
    <investigator>
      <last_name>Bang Wool Eom, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Keun Won Ryu, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Young-Woo Kim, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hong Man Yoon, MD,MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Il Ju Choi, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Chan Gyoo Kim, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Soo-Jeong Cho, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Young-Il Kim, MD,MS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Myeong-Cherl Kook, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Soo Jin Kim, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ji Yoon Rho, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Seok Ki Kim, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Soonchunhyang University College of Medicine</name>
      <address>
        <city>Bucheon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>In Cho, MD</last_name>
      <email>join34@hanmail.net</email>
    </contact>
    <investigator>
      <last_name>Gyu Seok Cho</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>In Cho</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Dongnam Institute of Radiological and Medical Science</name>
      <address>
        <city>Busan</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jae-Seok Min, MD, PhD</last_name>
      <email>mdoogy@hanmail.net</email>
    </contact>
    <investigator>
      <last_name>Jae-Seok Min, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gyeongsang National University Changwon Hospital</name>
      <address>
        <city>Changwon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sang-Ho Jeong, MD, PhD</last_name>
      <email>jshgnuh@naver.com</email>
    </contact>
    <investigator>
      <last_name>Sang-Ho Jeong, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tae-Han Kim, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kyungpook National University Medical Center</name>
      <address>
        <city>Daegu</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ji Yeon Park, MD, MS</last_name>
      <email>jybark990118@naver.com</email>
    </contact>
    <investigator>
      <last_name>Ji Yeon Park, MD, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Chonnam National University Hwasun Hospital</name>
      <address>
        <city>Hwasun</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Young Kyu Park, MD, PhD</last_name>
      <phone>82-61-379-7644</phone>
      <email>parkyk@jnu.ac.kr</email>
    </contact>
    <investigator>
      <last_name>Young Kyu Park, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Oh Jeong, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mi-Ran Jung, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Gyeongsang National University Hospital</name>
      <address>
        <city>Jinju</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ji-Ho Park, MD</last_name>
      <email>goodgsdr@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Ji-Ho Park, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Samsung Medical Center</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jun Ho Lee, MD,PhD</last_name>
      <email>gsjunholee@gmail.com</email>
    </contact>
    <investigator>
      <last_name>Jun Ho Lee, MD,PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ji Young An, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ajou University School of Medicine</name>
      <address>
        <city>Suwon</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hoon Hur, MD, PhD</last_name>
      <email>hhcmc75@naver.com</email>
    </contact>
    <investigator>
      <last_name>Hoon Hur, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 10, 2017</study_first_submitted>
  <study_first_submitted_qc>April 18, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 21, 2017</study_first_posted>
  <last_update_submitted>May 3, 2018</last_update_submitted>
  <last_update_submitted_qc>May 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 4, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>National Cancer Center, Korea</investigator_affiliation>
    <investigator_full_name>Bang Wool Eom</investigator_full_name>
    <investigator_title>Staff surgeon</investigator_title>
  </responsible_party>
  <keyword>Sentinel lymph node</keyword>
  <keyword>Early gastric cancer</keyword>
  <keyword>Non-curative endoscopic resection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stomach Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

